JPS6058073A - Dna - Google Patents

Dna

Info

Publication number
JPS6058073A
JPS6058073A JP58165065A JP16506583A JPS6058073A JP S6058073 A JPS6058073 A JP S6058073A JP 58165065 A JP58165065 A JP 58165065A JP 16506583 A JP16506583 A JP 16506583A JP S6058073 A JPS6058073 A JP S6058073A
Authority
JP
Japan
Prior art keywords
dna
protein
plasmid
bacillus
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58165065A
Other languages
Japanese (ja)
Other versions
JPH0158950B2 (en
Inventor
Juzo Udaka
重三 鵜高
Norihiro Tsukagoshi
規弘 塚越
Hideo Yamagata
山形 秀夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP58165065A priority Critical patent/JPS6058073A/en
Publication of JPS6058073A publication Critical patent/JPS6058073A/en
Publication of JPH0158950B2 publication Critical patent/JPH0158950B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus

Abstract

NEW MATERIAL:DNA having promotor activity of gene to code protein of surface layer of Bacillus brevis. USE:A promoter having high activity. Being inserted into a plasmid capable of multiplying in the cell of Escherichia coli, bacterium belonging to the genus Bacillus, etc. PREPARATION:For example, chromosome DNA of Bacillus brevis 47 mold (FERM-P 7224) is partially hudrolyzed with restricted enzyme Hind III, to give linear DNA having various length. While, plasmid pBR322 is similarly treated, to give linear plasmid pBR322, which is blended with linear DNA, and treated with T4DNA ligase so that both are linked. The linked DNA is transformed with Escherichia coli HB101, cultivated in L-broth medium containing ampicillin, to give a transformed strain having ampicillin resistance. A rabbit antibody to a mixture of protein constituting surface layer structure of Bacillus brevis 47 mold, having 130,000 and 150,000 molecular weight is prepared, and NT-100 strain is obtained from the transformed strain by the use of this antiserum.

Description

【発明の詳細な説明】 本発明はDNAに関し、詳しくはプロモーターJf−M
、セー宕−J−V w %I A I+r FilA 
→ト # J tl +ys k x本発明者らは、バ
チルス・プレビス(Bacillusbrevis )
の表層蛋白質が菌体外に多量に生産されることに着目し
、そのプロモーターを単離するこトt−試み、遂にバチ
ルス・プレビスの表層蛋白質をコードする遺伝子のプロ
モーター活性を有するI)HAを分離することに成功し
たのである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to DNA, and in particular to promoter Jf-M.
, Sega-J-V w %I A I+r FilA
→t # J tl +ys k x The present inventors have discovered that Bacillus brevis
Noting that the surface protein of Bacillus plebis is produced in large quantities outside of the bacterial cell, we attempted to isolate its promoter, and finally found I) HA that has the promoter activity of the gene encoding the surface protein of Bacillus plebis. They succeeded in separating it.

すなわち、ベクターとして大腸菌のプラスミドpBR5
22を選択し、該プラスミドpBR522を制限酵素H
1n4 [1で切断し、5′末端のリン酸基をバクチリ
アル・アルカリン替ホスファターゼ(Bacteria
laljcaline phosphatase )処
理によって除き線状のプラスミドpBR522を調製し
た。一方、バチルス・プレビス47菌の細胞から斉藤・
三浦の方法(Bi−oahirn。
That is, E. coli plasmid pBR5 was used as a vector.
22 was selected, and the plasmid pBR522 was digested with restriction enzyme H
1n4 [1], and the 5'-terminal phosphate group was cleaved with bacterial alkaline replacement phosphatase (Bacteria
A linear plasmid pBR522 was prepared by treatment with (aljcaline phosphatase). On the other hand, from cells of 47 Bacillus plevis bacteria, Saito
Miura's method (Bi-oahirn.

Biophys、 Acta、 72.619 (19
65) )によって染色体DNAを調製してドナーDN
Aに供した。この染色体DNAを制限酵素H1n+1l
llで部分加水分解して種々の長さの線状DNAを調製
した。次に、線状プラスミドpER322と線状DNA
を混合し、T4DNAIJガーゼで両者を連結した。連
結したDNAを大腸菌HB101にLehrberg 
、 B、 M、 and 0ohen 、 S、 H。
Biophys, Acta, 72.619 (19
65) Prepare donor DNA by preparing chromosomal DNA by
Served to A. This chromosomal DNA is digested with restriction enzyme H1n+1l.
Linear DNAs of various lengths were prepared by partial hydrolysis with ll. Next, linear plasmid pER322 and linear DNA
were mixed and the two were ligated with T4DNAIJ gauze. The ligated DNA was transferred to E. coli HB101 by Lehrberg.
, B.M., and Oohen, S.H.

の方法(J、 Bacteriol、、 19.107
2−1074(1974))により形質転換し、これを
L−ブロス培地(トリプトン(Dirco ) 1%、
酵母エキス(Difco ) 0.5%、1JaOtO
,5%、MgSO4117400,025%r pH7
,2)にアンピシリン50μ?/dを加えたものに培養
してアンピシリン耐性の形質転換株を得た。
method (J, Bacteriol, 19.107
2-1074 (1974)), and this was transformed into L-broth medium (tryptone (Dirco) 1%,
Yeast extract (Difco) 0.5%, 1 JaOtO
,5%, MgSO4117400,025%r pH7
,2) ampicillin 50μ? /d was added to obtain an ampicillin-resistant transformant.

こレラの形質転換株からバチルス・プレビス47の表層
構造蛋白質をコードする遺伝子を有するクローンを以下
の方法によって選択した。
A clone having a gene encoding the surface structure protein of Bacillus plevis 47 was selected from the transformed strain of C. cholerae by the following method.

バチルス・プレビス47の表層構造体は分子量13万と
分子量15万の主要蛋白質から構成されている。これら
蛋白質の混合物に対するウサギ抗体を調製し、この抗血
清を用いて上記形質転換株の中から表層構造体を構成す
る蛋白質遺伝子を含むクローンをKemp 、 D、 
J、 sn6 Qowmtm、 A、 ?、の方法(P
roa、 Natl、 Acad、 Sci、 U8A
 、 78 、4520〜4524(1981))によ
シ選択してNT100株を得た。
The surface structure of Bacillus plebis 47 is composed of major proteins with molecular weights of 130,000 and 150,000. A rabbit antibody against a mixture of these proteins was prepared, and using this antiserum, a clone containing the protein gene constituting the surface structure was isolated from among the above-mentioned transformed strains by Kemp, D.
J, sn6 Qowmtm, A, ? , the method (P
roa, Natl, Acad, Sci, U8A
, 78, 4520-4524 (1981)) to obtain strain NT100.

このクローンについて分子量15万と分子量15万の蛋
白質のそれぞれに対する抗体との反応性について検討し
たところ分子量15万の表層構造蛋白質の抗体とのみ反
応する蛋白質を生産することが判った。
When this clone was examined for its reactivity with antibodies to proteins with a molecular weight of 150,000 and 150,000, it was found that it produced a protein that reacted only with antibodies to a surface structure protein with a molecular weight of 150,000.

第1図はNT100株に含まれるプラスミドpNT10
0の制限酵素地図である。図中、太線部分はバfkス・
プレビス47由来の染色体D N A ヲ示している。
Figure 1 shows plasmid pNT10 contained in the NT100 strain.
0 restriction enzyme map. In the figure, the thick line part is the bus fk
Chromosomal DNA derived from Plebis 47 is shown.

次に、プラスミドpNT 100を各種制限酵素(Hl
ndlll 、 HpaI 、 BamHI)を用いて
切断し1再連結することによって種々の長さのプラスミ
ドを調製した。これらプラスミドを用いて前記した方法
によって大腸菌HB101を形質転換し、分子量15万
の表層蛋白質に対する抗体を用いて前記と同様にして抗
原抗体反応を行なって分子量15万の表層蛋白質を生産
するクローンについて調べ、pNT 100 中のプリ
モータ一部位を決定[また。その結果、第1図における
b7ラグメントに分子bt15万の表層蛋白質のプロモ
ーター活性を示すDNA配列が存在することが明らかと
71つプこ。すなわち、このDNAはDNA鎮中にBa
mHIで切断される個所、その291bp下流に)li
nf Iで切断される個所、その156 bp下流にA
luiで切断される個所およびその268 bp下流に
HpaIで切断される個所を有している。
Next, plasmid pNT 100 was injected with various restriction enzymes (Hl
Plasmids of various lengths were prepared by cutting with ndlll, HpaI, BamHI) and religating. E. coli HB101 was transformed using these plasmids by the method described above, and an antigen-antibody reaction was performed in the same manner as above using an antibody against a surface protein with a molecular weight of 150,000 to examine clones that produced a surface protein with a molecular weight of 150,000. , determine the primer site in pNT 100 [also. As a result, it is clear that there are 71 DNA sequences in the b7 fragment shown in Figure 1 that exhibit the promoter activity of a surface protein with a molecular weight of 150,000 bt. In other words, this DNA is Ba
291 bp downstream of the site cleaved by mHI)li
nf I, 156 bp downstream of A
It has a site that is cleaved with lui and a site that is cleaved with HpaI 268 bp downstream thereof.

本発明のDNAは、細菌細胞、たとえば大腸菌やバチル
ス屈の微生物の細胞内で増殖することができるプラスミ
ドに挿入すれば、活性の高いプロモーターとしての機能
を発揮する。すなわち、プラスミド内に挿入されたプロ
モーターDNAの下流に有用な外来遺伝子を接続せしめ
、得られた組換えDNAを大腸菌またはバチルス氏微生
物の細胞内に導入ずれは、これら微生物は蛋白質等の有
用物質を多足に生産するように形質転換される。
When the DNA of the present invention is inserted into a plasmid that can proliferate in bacterial cells, such as Escherichia coli or Bacillus flexor microorganisms, it will function as a highly active promoter. That is, by connecting a useful foreign gene downstream of the promoter DNA inserted into a plasmid and introducing the obtained recombinant DNA into the cells of Escherichia coli or Bacillus microorganisms, these microorganisms can absorb useful substances such as proteins. Transformed to produce polypods.

ここで外来遺伝子の例としては真核生物由来のものおよ
び原核生物由3ドのもののいずれも使用することが可能
である。たとえはヒト遺伝子(たとえばインター7エリ
ン、インシュリンなど) 、 uE物の酵素蛋白遺伝子
(たとえばトリプトファナーゼ、アスパラギン酸アンモ
ニアリアーゼなど)などがある。
Examples of foreign genes here include those derived from eukaryotes and those derived from prokaryotes. Examples include human genes (eg, inter7erin, insulin, etc.), enzyme protein genes of uE products (eg, tryptophanase, aspartate ammonia lyase, etc.).

限酵素Bind[[で部分加水分解し、種々の長さの線
状DNAを調製した。一方、プラスミドpBB 522
も制限酵素H1nLl[lで切断し、5′末端のリン酸
基をバクチリアルφアルカリ・ホスファクーゼ処理によ
り除去して線状プラスミドpBR522を調製した。
Linear DNAs of various lengths were prepared by partial hydrolysis with the limiting enzyme Bind[[. On the other hand, plasmid pBB 522
A linear plasmid pBR522 was prepared by cutting the plasmid with the restriction enzyme H1nLl[l and removing the 5'-end phosphate group by bacterial φ alkaline phosphacose treatment.

これら線状DNAを混合し、T、DIIAリガーゼを作
用させて両DNAを連結した。
These linear DNAs were mixed, and both DNAs were ligated by the action of T and DIIA ligase.

連結したDNAを大腸菌HB101にLederber
g、 H。
Lederber the ligated DNA into E. coli HB101.
g, H.

M、aaxd 0ohen 、 8. N、の方法(J
、 Baateriol。、す1゜1072〜1074
 (1974))によって形質転換し、さらにI+ −
broth培地にアンピシリン50μF!−/ldを加
えた培地に塗布して培養し、アンピシリン耐性の形質転
換株を得た。
M, aaxd 0ohen, 8. N, method (J
, Baateriol. , Su1゜1072~1074
(1974)) and further transformed with I+ −
Ampicillin 50μF in broth medium! -/ld was applied to a medium and cultured to obtain an ampicillin-resistant transformant.

次に、バチルス・プレビス47菌の表層構造体を構成す
る分子量13万と15万の蛋白質の混合物に対するウサ
ギ抗体を調製し、この抗血清を使用して上記形質転換株
中よシ表層構造体構成蛋白m ’m M ff−j 4
 争−)+ −−/ シー v+艷η TT T aM
+4 1’!AWm6YA、 F、の方法(Proc、
 Natl、 Aoad、 Sci、 USA 、 7
8.4520〜4524 (1981))によシ選択し
てNT100株を得た。この1JT100株について分
子IIk13万と15万のそれぞれの蛋白質に対する抗
体との反応性を検討したところ、この菌株は分子量15
万の表層構造蛋白質の抗体とのみ反応する蛋白質を生産
していることが明らかとなった。
Next, a rabbit antibody against a mixture of proteins with molecular weights of 130,000 and 150,000 that constitutes the surface structure of Bacillus plebis 47 was prepared, and this antiserum was used to construct the surface structure of Bacillus plevis in the above-mentioned transformed strain. Protein m 'm M ff-j 4
-) + --/ Sea v+艷η TT T aM
+4 1'! AWm6YA, F, method (Proc,
Natl, Aoad, Sci, USA, 7
8.4520-4524 (1981)) to obtain the NT100 strain. When we examined the reactivity of this 1JT100 strain with antibodies against proteins with molecular IIk of 130,000 and 150,000, we found that this strain had a molecular weight of 15,000.
It has become clear that the protein that reacts only with antibodies of surface structural proteins of 10,000 yen is produced.

このNT100株を用いてBirnboin 、 H,
O,、Doly、 、r。
Using this NT100 strain, Birnboin, H.
O,, Doly, ,r.

(Nucleio Ac1ds Rea、、7 、15
15−1525(1979))の方法によりプラスミド
の検出および分子量の測定を行なった。その結果、分子
量は6.I X 106ダルトンであシ、このプラスミ
ドをpnTlao と命名した。pHT100の制限酵
素切断地図は第1図に示し九通フである。
(Nucleio Ac1ds Rea, 7, 15
15-1525 (1979)) to detect the plasmid and measure its molecular weight. As a result, the molecular weight was 6. This plasmid was named pnTlao. The restriction enzyme cleavage map for pHT100 is shown in FIG.

プラスミドpNT 100を各種制限酵素(H1n4n
1゜HpaI、 BamHl )を用いて切断し、再連
結することによシ種々の長さのプラスミド7種を詞製し
、これらのプラスミドを上記した方法によシ大腸菌HB
101に形質転換し、7種類のクローンを得、分子量1
5万の表層構造蛋白質に対する抗体を用いて上記方法と
同様にして抗原抗体反応を行ない、分子量15万の表層
構造蛋白質のプロモータ一部位を決定した。以下にその
詳細を示す。
Plasmid pNT 100 was digested with various restriction enzymes (H1n4n
Seven plasmids of various lengths were prepared by cutting with 1°HpaI, BamHl) and religating, and these plasmids were isolated from E. coli HB by the method described above.
101 and obtained 7 types of clones, with a molecular weight of 1
An antigen-antibody reaction was carried out in the same manner as described above using an antibody against a surface structure protein of 50,000, and the promoter site of a surface structure protein with a molecular weight of 150,000 was determined. The details are shown below.

(111(1ndl[[を用いた実験 プラスミドpNT 100をHlndlで切断し、再連
結を行なうと、5 Kl)の)IindInD N A
 7ラダメントだけで分子ff115万の蛋白質の抗体
と反応する蛋白質を大腸菌は生産した(第2図B)。木
V’11!+echerichia coli HB 
101 / pNT 100は微工研にP!!inM 
P−7231として寄託されている◎(21Hp&Iを
用いた実験 プラスミドpNT 100をHpaIで切断し、再連結
し、分子fij115万の蛋白質の抗体と反応する蛋白
質を生産する大腸菌の中に含まれるプラスミドを分析し
た結果、第2図0.D、Eの3種類の株が得られた。す
なわち、第1図に示したCフラグメント(Hpai−B
amHl、 400 bp) 、 bフラグメント(B
amaI −Hpal 、 715 bp )およびC
7ラグメント(1(paI−Hpai 、 215 b
p )の連結の仕方が種々異なっていた。クローンDで
はB、b、cのフラグメントの連結の仕方はpNT 1
00 と全く逆方向であり、かつ分利15万の蛋白質の
抗体と反応する蛋白質を生産していた。また、クローン
EではCフラグメントが欠けていたが、クローンDと同
様に分子ji15万の蛋白質の抗体と反応する蛋白質を
生産していた。したがって、分子量15万の蛋白質のプ
ロモーターはa、b7ラグメント中に存在することが明
らかである。
IindInDNA
Escherichia coli produced a protein that reacted with the antibody of 1,150,000 molecules of protein with only 7 radaments (Fig. 2B). Thursday V'11! +echerichia coli HB
101/pNT 100 is P to Microtechnical Research Institute! ! inM
The plasmid pNT 100 deposited as P-7231 (experiment using Hp&I) was cut with HpaI and religated to generate a plasmid contained in E. coli that produces a protein that reacts with the antibody of the protein molecule fij1.15 million. As a result of the analysis, three types of strains, 0.D and E in Figure 2, were obtained.In other words, the C fragment (Hpai-B
amHl, 400 bp), b fragment (B
amaI-Hpal, 715 bp) and C
7 fragment (1 (paI-Hpai, 215 b
There were various ways of connecting p). In clone D, the method of ligation of fragments B, b, and c is pNT 1
00, and produced a protein that reacted with the antibody of a protein with a molecular weight of 150,000. Furthermore, clone E lacked the C fragment, but like clone D, it produced a protein that reacted with the antibody of a protein with a molecule of 150,000 molecules. Therefore, it is clear that the promoter of a protein with a molecular weight of 150,000 exists in the a, b7 fragment.

T31 EaffIHi、 Hph■両制限酵素を用い
た実験プラスミドpliT 100をBamHIとHp
a) テ切断し1再連続して分利15万の蛋白質の抗体
と反応する蛋白質を生産する大腸菌としてクローンF(
本菌E、 coli HB 101 /pNT 152
は微工研にFl!!BMF−7250として寄託されて
いる。)が得られた。第2図に示したように、クローン
rは&7ラグメントが欠けているが、分子量15万の蛋
白質の抗体と反応する蛋白質を生産している。また、b
7ラグメントのみを有するプラスミドルN丁142を導
入したクローンG(本閑見竺見HB 101/pNT 
142)は以上のように、クローンA −(Jはいずれ
も分子量15万の蛋白質の抗体との反応性が陽性である
蛋白質を生成する。これらの結果に基いて総合的に判断
すると、第1図におけるbフラグメントに分子量15万
の蛋白質のプロモーター活性を示すDNA配列が存在す
る0
Experimental plasmid pliT 100 using both restriction enzymes, BamHI and Hph
a) Clone F (
This bacterium E, coli HB 101 /pNT 152
Fl! ! It has been deposited as BMF-7250. )was gotten. As shown in FIG. 2, clone r lacks the &7 fragment, but produces a protein with a molecular weight of 150,000 that reacts with the antibody. Also, b
Clone G (Honkanmi Jikumi HB 101/pNT
As mentioned above, clones A-(J) produce proteins that are positive in reactivity with the antibody of a protein with a molecular weight of 150,000. Judging comprehensively based on these results, clones A-(J) There is a DNA sequence in fragment b in the figure that shows the promoter activity of a protein with a molecular weight of 150,000.

【図面の簡単な説明】[Brief explanation of drawings]

第1図はプラスミドplJT100の制限酵素地図、第
2図は大腸菌に導入された各種のプラスミドを示す。 q!許出出願人 鵜 高 重 三 第1図 = 第2図 ←B、brevis DNA−一船一叩ER322−−
−→マ Hindエエエ W Hpa工 ψ BamH工 (#bf)p) 手続補正書(自発) 昭和58年10月6 日 特許庁長官 若杉和夫 殿 1、 事件の表示 特願昭58−165065 λ 発明の名称 NA 五 補正をする者 事件との関係 特許出願人 鵜高重三 4、代理人 〒104 東京都中央区京橋1丁目1番10号 & 補正の対象 明細書の発明の詳細な説明の簡 & 補正の内容 明細書第7頁8行目の「Birnboin 、 11、
C5,」 を「Birnboim 、 l(、0,、J
に訂正する。
FIG. 1 shows a restriction enzyme map of plasmid plJT100, and FIG. 2 shows various plasmids introduced into E. coli. q! Applicant: Shige Uko Takashi Figure 1 = Figure 2 ← B, brevis DNA - One ship, one hit ER322 -
−→Ma HindEeeW Hpa Engineering ψ BamH Engineering (#bf) p) Procedural amendment (spontaneous) October 6, 1980 Commissioner of the Japan Patent Office Kazuo Wakasugi 1, Indication of Case Patent Application 165065 1982 λ Invention Name NA 5 Relationship to the case of the person making the amendment Patent applicant Shigezo Udaka 4, agent 1-1-10 Kyobashi, Chuo-ku, Tokyo 104 & Brief detailed explanation of the invention of the specification subject to amendment & “Birnboin, 11,” on page 7, line 8 of the specification of contents of the amendment.
C5,” to “Birnboim, l(,0,,J
Correct.

Claims (1)

【特許請求の範囲】 1、 バチルス・プレビスの表層蛋白質をコードする遺
伝子のプロモーター活性を有するDNA。 2、I)HA鎖中KB&l1)IIで切断される個所、
その291 bp下流にHLnf Iで切断される個所
、そのl 56 bpT流にAlu lで切断される個
所およびその268 bp下流にHpaIで切断される
個所を有する特許請求の範囲第1項記載のDNA。 & 細菌細胞内で増殖しうるプラスミドに挿入されてい
る特許請求の範囲第1項または第2項記載のD N A
 。 4、 細菌細胞内で増殖しつるプラスミドに挿入されて
細菌細胞内に導入されている特許請求の範囲第1項また
は第2項記載のDNA。
[Scope of Claims] 1. DNA having promoter activity of a gene encoding a surface protein of Bacillus plevis. 2. I) KB&l1) cleavage site in II in HA chain,
The DNA according to claim 1, which has a site cleaved with HLnf I 291 bp downstream thereof, a site cleaved with Alu I in the 1 56 bpT stream, and a site cleaved with Hpa I 268 bp downstream thereof. . & The DNA according to claim 1 or 2, which is inserted into a plasmid that can proliferate in bacterial cells.
. 4. The DNA according to claim 1 or 2, which is introduced into bacterial cells by being inserted into a plasmid that proliferates in bacterial cells.
JP58165065A 1983-09-09 1983-09-09 Dna Granted JPS6058073A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58165065A JPS6058073A (en) 1983-09-09 1983-09-09 Dna

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58165065A JPS6058073A (en) 1983-09-09 1983-09-09 Dna

Publications (2)

Publication Number Publication Date
JPS6058073A true JPS6058073A (en) 1985-04-04
JPH0158950B2 JPH0158950B2 (en) 1989-12-14

Family

ID=15805192

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58165065A Granted JPS6058073A (en) 1983-09-09 1983-09-09 Dna

Country Status (1)

Country Link
JP (1) JPS6058073A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326046A2 (en) * 1988-01-25 1989-08-02 Takeda Chemical Industries, Ltd. Production of human epidermal growth factor
US4994380A (en) * 1985-11-07 1991-02-19 Shigezo Udaka Process for expressing genes by Bacillus brevis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994380A (en) * 1985-11-07 1991-02-19 Shigezo Udaka Process for expressing genes by Bacillus brevis
EP0326046A2 (en) * 1988-01-25 1989-08-02 Takeda Chemical Industries, Ltd. Production of human epidermal growth factor

Also Published As

Publication number Publication date
JPH0158950B2 (en) 1989-12-14

Similar Documents

Publication Publication Date Title
Bragg et al. Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis
Bolken et al. Inactivation of the srtA gene in Streptococcus gordonii inhibits cell wall anchoring of surface proteins and decreases in vitro and in vivo adhesion
De Smet et al. Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis
Wong et al. Transcriptional and translational start sites for the Bacillus thuringiensis crystal protein gene.
EP0012494A1 (en) A DNA transfer vector, a microorganism modified by said vector and the synthesis of a eucaryotic protein by the modified microorganism
Dandekar et al. A single base pair change in proline biosynthesis genes causes osmotic stress tolerance
Lee et al. The priA gene encoding the primosomal replicative n'protein of Escherichia coli.
JPH0811069B2 (en) Construction of IgG-binding proteins to promote downstream processing using protein engineering
MXPA01003770A (en) Stabilized bioactive peptides and methods of identification, synthesis and use.
Akutsu et al. Molecular structure and immunity specificity of colicin E6, an evolutionary intermediate between E-group colicins and cloacin DF13
Griswold et al. Characterization of the arginine deiminase operon of Streptococcus rattus FA-1
Benoit et al. Topological analysis of the aerobic membrane-bound formate dehydrogenase of Escherichia coli
CN116635525A (en) Cyclic RNA vaccines and methods of use thereof
Tsurimoto et al. Bacteriophage lambda initiators: preparation from a strain that overproduces the O and P proteins
Wang et al. Bacillus subtilis dnaE encodes a protein homologous to DNA primase of Escherichia coli.
Shaw et al. Mutational analysis of the dimethylsulfoxide respiratory (dor) operon of Rhodobacter capsulatus
Jeffke et al. Mutational analysis of the cbb operon (CO2 assimilation) promoter of Ralstonia eutropha
Ariansen et al. Membrane translocation of diphtheria toxin A-fragment: role of carboxy-terminal region
JP2540484B2 (en) Gene coding for insecticidal protein
JPS6058073A (en) Dna
Han et al. Effect of IciA protein on the expression of the nrd gene encoding ribonucleoside diphosphate reductase in E. coli
Griffith et al. An N-terminal domain of the tetracycline resistance protein increases susceptibility to aminoglycosides and complements potassium uptake defects in Escherichia coli
Scholle et al. Nucleotide sequence and analysis of the Vibrio alginolyticus sucrase gene (scrB)
Schray et al. Binding of human glutaminyl-tRNA synthetase to a specific site of its mRNA
Pohlner et al. Nucleotide sequence of ompV, the gene for a major Vibrio cholerae outer membrane protein